Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

Conditions: Nonalcoholic Fatty Liver; Nonalcoholic Steatohepatitis; Fibrosis, Liver; Type 1 Diabetes; Cirrhosis, Liver
Interventions: Device: Transient Elastography
Sponsors: Joslin Diabetes Center
Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 13, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments